What factors affect the chronic prognosis of lymphocytic leukemia?
There is no medicine for chronic lymphocytic leukemia (CLL), one of the most commonly diagnosed leukemia in the western hemisphere. The disease can proceed very slowly, take many years to require treatment, or can be aggressive and require immediate intervention. Several factors affect the chronic prognosis of lymphocytic leukemia, including clinical traits, serum markers and the general health of the patient.
Cll is a cancer in which blood produces too many lymphocyte blood cells. The cause of CLL is unknown, although scientists have determined that the tendency to develop CLL is not inherited. Changes in DNA structure in CLL take place after the patient's birth, not before birth. This leads to the scientist to the belief that CLL can cause DNA changes.
Clinical features are compiled and represent the evaluation of phase 0 to phase V. The average chronic prognosis of lymphocytic leukemia for phase 0 is 150 months, while the prognosis for the stadium V is 19 months. Within the range of all phases, general health and reaction toMedical care also comes into play. The patient's gender and age are also considered in the calculation of clinical signs for chronic prognosis of lymphocytic leukemia.
Lymphocyte test is usually performed at six -month intervals after initial diagnosis. Doubling lymphocytes in any six -month period usually causes recommendations to start treatment. The patient's age to the prognosis because the elderly patient will be less able to tolerate aggressive treatment.
serum markers also indicate the overall level of survival, independent of other factors. The lower the speed of serum, a better chance of long -term remission and survival. Higher serum speed shortens the expected survival rate.
The prognosis of chronic lymphocytic leukemia also depends on whether it is a new diagnosis or relapse after patient was in remission. In addition, changes in certain DNA markers are prognosis. Some cases of CLLwill eventually become a lymphoma when the prognosis is modified for a new type of cancer. General overall health is an important factor in the forecast of all cancers, including chronic lymphocytic leukemia. Patients who are younger, the right weight and without other health problems are usually better suited during cancer treatment than patients in poor general health.